Drug-induced movement disorder: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2004 to 2024
Our disproportionality analysis and sensitivity analysis of the FAERS database identified drugs potentially associated with DIMDs. These findings can provide valuable information for clinicians to be more cautious when prescribing these drugs and to monitor patients for the development of movement disorders closely. Additionally, the results can help regulatory agencies make informed decisions regarding the safety of drugs.
Authors
- Guohao Peng
- Zhongjie Cai
- Chenju Zhan (ORCID: https://orcid.org/0000-0002-0394-4029)
- Zou Jun (ORCID: https://orcid.org/0009-0001-5943-2604)
- Lingling Luo (ORCID: https://orcid.org/0000-0002-3787-6837)
- Jingjing Zou (ORCID: https://orcid.org/0000-0002-5564-2989)
- Yan Feng (ORCID: https://orcid.org/0000-0002-4974-7004)
- Qixi Liu
Institutions
- Fujian Medical University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1371/journal.pone.0335449
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31